Solventum Corp
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
SOLV$90.08-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Three months ended March 31, | ||
|---|---|---|
| (Millions) | 2026 | 2025 |
| Cash Flows from Operating Activities | ||
| Net income | $13 | $137 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities | ||
| Depreciation and amortization | 135 | 129 |
| Pension and postretirement benefits | 14 | 15 |
| Stock-based compensation expense | 51 | 49 |
| Deferred income taxes | (41) | (144) |
| Changes in assets and liabilities | ||
| Accounts receivable | (34) | 6 |
| Due from related parties | 28 | 5 |
| Inventories | (32) | (32) |
| Accounts payable | 23 | 9 |
| Due to related parties | (100) | (6) |
| Accrued compensation | (151) | (107) |
| All other operating activities — net | (94) | (32) |
| Net cash provided by (used in) operating activities | (189) | 29 |
| Cash Flows from Investing Activities | ||
| Purchases of property, plant and equipment | (84) | (109) |
| Other — net | 7 | (5) |
| Net cash used in investing activities | (77) | (114) |
| Cash Flows from Financing Activities | ||
| Repayment of debt | — | (100) |
| Proceeds from debt, net of issuance costs | 46 | — |
| Net transfers from (to) 3M | 2 | (31) |
| Purchases of treasury stock | (67) | — |
| Other — net | (31) | (8) |
| Net cash used in financing activities | (50) | (139) |
| Effect of exchange rate changes on cash and cash equivalents | (2) | 1 |
| Net increase (decrease) in cash and cash equivalents | (318) | (223) |
| Cash and cash equivalents at beginning of period | 878 | 762 |
| Less: cash and cash equivalents held for sale | — | (5) |
| Cash and cash equivalents at end of period | $561 | $534 |
| Supplemental Cash Flow Information | ||
| Non-cash investing and financing activity: | ||
| Right-of-use assets obtained in exchange for finance lease liability | $207 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.